Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Clinical Nutrition (Edinburgh, Scotland)|November 13, 2024
Metabolic and hepatic phenotypes in sarcopenic obesity and impact of bariatric surgeryVittoria Zambon Azevedo, Pierre Bel Lassen, Judith Aron-Wisnewsky, et al.
Clinics and Research in Hepatology and Gastroenterology|June 14, 2014
Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: "APRI c'est fini ?"Hugo Perazzo, Raluca Pais, Mona Munteanu, et al.
Obesity Surgery|December 31, 2024
Transjugular Intrahepatic Portosystemic Shunt (TIPS): A Bridge to Bariatric Surgery in Morbidly Obese Patients with Cirrhosis and Clinically Significant Portal HypertensionRaluca Pais, Yasmina Chouik, Lucile Moga, et al.
Alimentary Pharmacology & Therapeutics|March 15, 2023
Review article: The need for more efficient and patient-oriented drug development pathways in NASH-setting the scene for platform trialsJuan M Pericàs, Nicholas A Di Prospero, Quentin M Anstee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 3, 2014
Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplantsRaluca Pais, Pascal Lebray, Geraldine Rousseau, et al.
European Journal of Gastroenterology & Hepatology|December 3, 2019
Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetesThierry Poynard, Valentina Peta, Olivier Deckmyn, et al.
Alimentary Pharmacology & Therapeutics|October 19, 2018
Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver diseaseMona Munteanu, Raluca Pais, Valentina Peta, et al.
Diabetes & Metabolism|October 17, 2025
Management of patients with type 2 diabetes and MASLD: An overview and joint statementYasmina Chouik, Clémence M Canivet, Jean-Baptiste Julla, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2018
LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosisThierry Poynard, Valentina Peta, Olivier Deckmyn, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 14, 2019
Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced FibrosisJavier Ampuero, Raluca Pais, Rocío Aller, et al.
Pageof 6